MaxCyte, Inc.MXCTNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-3.70
↑ 94% vs avg
Percentile
P100
Near historical high
Streak
5 yr
Consecutive growthElevated
Average
-62.52
Historical baseline
PeriodValueYoY Change
2025-3.70+65.2%
2024-10.62+17.0%
2023-12.80+45.7%
2022-23.56+51.3%
2021-48.39+51.6%
2020-99.94-34.4%
2019-74.35+24.2%
2018-98.10-17.7%
2017-83.39+51.0%
2016-170.31-